Asthma and Atopic Comorbidities

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States

Implications of the Atopic March on Practice

Allergic Sensitization and Allergic Diseases

Factors Associated With Atopic March

Epidemiology in Pediatric Population

Epidemiology in Pediatric Population (cont)

Examining Progression of Atopic March Classical or Heterogeneous?

Pathophysiology of Atopic March

What About EoE?

The Role of Asthma

Asthma As A Heterogeneous Disease How Can We Classify Patients?

Asthma As A Heterogeneous Disease How Can We Classify Patients? (cont)

A Closer Look at Pathways

Antigen Responsiveness at Early Age Indicates Risk of Later Disease

Consider the Limitations of the Atopic March

Understanding Disease Progression and Prophylaxis

Prophylaxis of Atopic March Which Potential Pathways to Block?

Is Early Intervention Effective?

Halting the Atopic March PAT Study

Halting the Atopic March SAM Study

SAM Study Results

Looking Forward Potential Treatment Options

Concluding Remarks

Abbreviations